On July 31, 2025, the 77th American Clinical Chemistry Conference and Exposition of Clinical Laboratory Medicine (ADLM) was successfully concluded in Chicago. As an innovative enterprise in China's IVD field, DIAGREAT Bio made a stunning appearance with its whole industry chain technology matrix from raw materials to equipment, not only showing the cutting-edge achievements of China's biotechnology to the world, but also winning a high degree of recognition from international customers with its professional products and innovations, and injecting a strong kinetic energy into its globalization strategy.
Full Matrix Products at ADLM
Demonstrating Strength and Global Recognition
At ADLM, DIAGREAT Bio showcased a full matrix of products covering advanced medical devices, multi-scenario solutions and high-quality IVD raw materials, which demonstrated its profound technological accumulation and innovative strength, as well as the breakthroughs in the development of Chinese IVD enterprises. During the exhibition, DIAGREAT Bio's booth attracted the attention of global customers, and the atmosphere of consultation and negotiation was warm, and the intention of cooperation continued to increase. As a benchmark IVD enterprise with independent innovation, Danta Biotech has built up technical barriers by virtue of the hard power of controlling the whole chain of “raw materials - equipment”, and has demonstrated the vitality of Chinese biotechnology through the in-depth exchanges with global customers, and the image of “Made in China” has been recognized internationally. The image of “China's Smart Manufacturing” has been recognized internationally.
Building a globalized development pattern
with R&D and innovation as the engine
DIAGREAT Bio has always taken R&D and innovation as the engine to drive the company's progress, and has set up a core R&D team that gathers interdisciplinary top talents to inject sustained kinetic energy for technological breakthroughs. At present, its core products have successfully passed the CE certification of the European Union, as well as Italy, Mexico, Venezuela, Ecuador and other countries with stringent access certification, which is not only an authoritative proof of the company's expertise in medical technology, but also highlights its technological leadership in the global market. In the globalization layout, DANDA Bio has built up a marketing network covering more than 60 countries and regions to build a solid foundation for business expansion, and its products have also gained deep recognition and industry praise in the global market.
